Vendor, San Jose, CA
CCS Associates, Inc.
UEI VCNRS52G5PG7, CAGE 3H9A1
5 awards and $4,234,895 obligated between July 28, 2026 and August 31, 2026, 60% under full and open competition, against 5.2 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Other Scientific and Technical Consulting ServicesNAICS 541690 | $4,234,895 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 3 |
| Full and Open Competition | 1 |
| Competed Under SAP | 1 |
| Small Business Set Aside - Total | 3 |
| Definitive Contract | 2 |
| Delivery Order | 2 |
| Purchase Order | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N91023C00054Definitive Contract, April 29, 2026, Full and Open Competition After Exclusion of Sources, 3 offers | NIH NCINational Institutes of Health | The Purpose of This Requirement Is to Provide Regulatory Services and Technical Support to the Division of Cancer Prevention (Dcp) at the NaNAICS 541690, PSC R499 | $3,224,181 |
| 75N91023C00055Definitive Contract, July 28, 2026, Full and Open Competition After Exclusion of Sources, 1 offers | NIH NCINational Institutes of Health | Eo 14398 This Contract Provides a Variety of Critical Cancer Prevention Information Management Functions Necessary to Support the IdentificaNAICS 541690, PSC R499 | $651,949 |
| 75N95026F00001Delivery Order, March 25, 2026, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Regulatory Preparation, Review, and Submission for Clinical Trials Associated with Nida Drug Supply Program. N01DA-23-8933. March 27, 2026 tNAICS 541690, PSC B528 | $335,910 |
| 75N98026F00001Delivery Order, August 27, 2026, Full and Open Competition After Exclusion of Sources, 3 offers | National Institutes of Health OlaoNational Institutes of Health | Regulatory Support for Lead Gene Therapy Candidates as a Treatment for Congenital Myasthenic SyndromesNAICS 541690, PSC R499 | $159,116 |
| 75N95023P00692Purchase Order, August 7, 2026, Competed Under SAP, 8 offers | National Institutes of Health NidaNational Institutes of Health | Medical Writing Consulting ServicesNAICS 541690, PSC R499 | $73,269 |
| 75N95025F00001Delivery Order, April 7, 2026, Full and Open Competition After Exclusion of Sources, 3 offers | National Institutes of Health NidaNational Institutes of Health | Exercise Option B for Regulatory Activities for Pcca and Mmab Gene Therapy ProductsNAICS 541690, PSC R499 | $44,788 |
| 75N93021D00040March 11, 2026, Full and Open Competition, 29 offers | National Institutes of Health NiaidNational Institutes of Health | The Purpose of This Modification Is to Revise Section J. List of Attachments, Item 1. Statement of Work. the Revision Removes Language LimitNAICS 541714, PSC AN42 | $0 |
| 75N95022D00013August 27, 2026, Full and Open Competition After Exclusion of Sources, 3 offers | National Institutes of Health NidaNational Institutes of Health | EO14398 Cro Support for Ncats Regulatory Affairs Support and Related ServicesNAICS 541690, PSC R499 | $0 |
| 75N95023D00025July 28, 2026, Full and Open Competition, 1 offers | National Institutes of Health NidaNational Institutes of Health | Regulatory Affairs Support. CCS Associates, INC. N01DA-23-8933. September 20, 2023 to September 19, 2028.NAICS 541690, PSC R699 | $0 |
| 75N95024F00001Delivery Order, May 28, 2026, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | FY26 Udo Initiative Regulatory Affairs Support. CCS Associates, INC. N01DA-23-8933. April 1, 2024 to March 31, 2025NAICS 541690, PSC R699 | -$0 |
| 75N95022F00002Delivery Order, May 28, 2026, Full and Open Competition After Exclusion of Sources, 3 offers | National Institutes of Health NidaNational Institutes of Health | FY26 Udo Initiative Regulatory Support for Preparation and Filing of a Pre-Investigational New Drug (Pre-Ind) Application with the Food and NAICS 541690, PSC R499 | -$281 |
| 75N95022F00001Delivery Order, May 28, 2026, Full and Open Competition After Exclusion of Sources, 3 offers | National Institutes of Health NidaNational Institutes of Health | FY26 Udo Initiative Preparation of an Investigational New Drug (Ind) Application with Food and Drug Administration (Fda) for a Treatment forNAICS 541690, PSC R499 | -$1,457 |
| 75N91018C00030Definitive Contract, June 11, 2026, Full and Open Competition After Exclusion of Sources, 3 offers | NIH NCINational Institutes of Health | Technical Information Research for Cancer Preventive Agent Development. Period of Performance: 09/30/2022 - 09/29/2023NAICS 541690, PSC R499 | -$1,903 |
| 75N95020P00589Purchase Order, June 2, 2026, Competed Under SAP, 5 offers | National Institutes of Health NidaNational Institutes of Health | FY26 Udo Initiative Medical Writing Consulting and Drug Dossier Development Support ServicesNAICS 541990, PSC R499 | -$2,038 |
| 75N91018C00017Definitive Contract, June 11, 2026, Full and Open Competition After Exclusion of Sources, 2 offers | NIH NCINational Institutes of Health | Regulatory Support for Cancer Prevention Agent DevelopmentNAICS 541690, PSC R499 | -$37,017 |
- Places of performance
- CaliforniaMaryland
- Product and service codes
- R499 Other Professional ServicesB528 Regulatory Studies
- Transactions
- 8 across 5 awards